Evidence map›Paper›PMID 40756445›Full record

ArticleCanadian journal of kidney health and disease2025

Frequency, Management, and Outcomes of Outpatient Hyperkalemia: A Population-Based Cohort Study.

Michael Chiu, Nivethika Jeyakumar, Graham Smith, Danielle M Nash, Mohamed Abou El Hassan, Dana Bailey, Peter Catomaris, Kika Veljkovic, Louise Moist, Amit X Garg and 1 more

Abstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Emergency department referral and short-term death after outpatient hyperkalemia: a population-based study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michael ChiuDivision of Nephrology, Department of Medicine, Western University, and London Health Sciences Centre, ON, Canada.ORCID https://orcid.org/0000-0003-1192-0542
Nivethika JeyakumarICES Western, London Health Sciences Centre Research Institute, ON, Canada.
Graham SmithICES Western, London Health Sciences Centre Research Institute, ON, Canada.
Danielle M NashICES Western, London Health Sciences Centre Research Institute, ON, Canada.
Mohamed Abou El HassanDepartment of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada.
Dana BaileyDepartment of Pathobiology and Laboratory Medicine, Sinai Health, University of Toronto, ON, Canada.
Peter CatomarisDynacare, Brampton, ON, Canada.
Kika VeljkovicLifeLabs, Toronto, ON, Canada.
Louise MoistDivision of Nephrology, Department of Medicine, Western University, and London Health Sciences Centre, ON, Canada.ORCID https://orcid.org/0000-0003-3875-9197
Amit X GargDivision of Nephrology, Department of Medicine, Western University, and London Health Sciences Centre, ON, Canada.ORCID https://orcid.org/0000-0003-3398-3114
Arsh K JainDivision of Nephrology, Department of Medicine, Western University, and London Health Sciences Centre, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hyperkalemia is a potentially life-threatening condition, with guidelines recommending urgent treatment when the serum potassium level is greater than 6.0 mmol/L. However, these recommendations are inconsistent, leading to diverse approaches to patient care. Objectives: The primary objectives were to use population-based datasets to determine how often outpatient hyperkalemia (K > 6.2 mmol/L) occurs and how frequently patients present to the emergency department (ED) within 24 hours of the hyperkalemia report. Secondary objectives were to compare the characteristics of patients who had an ED encounter to those who did not, assess clinical outcomes within 7 days of the hyperkalemia report, and describe the initial potassium result within 24 hours of an ED encounter. Design: Retrospective cohort study using linked population-based datasets at ICES. Setting: Ontario, Canada from January 1, 2007, to December 24, 2021. Patients: Adult patients (≥18 years) not on dialysis with an outpatient hyperkalemia result >6.2 mmol/L who were identified through flagged and urgently communicated results from outpatient laboratories. Measurements: Emergency department encounters within 24 hours following an outpatient serum potassium report >6.2 mmol/L. Outcomes included all-cause mortality, cardiovascular mortality, arrhythmias, cardiac arrest in the ED, hospitalizations, and new dialysis starts within 7 days of the hyperkalemia report. Methods: Administrative healthcare data were linked with laboratory results to compare baseline characteristics, medication use, healthcare utilization, and clinical outcomes for all patients. Standardized differences were used for comparisons. Results: There were over 65 million serum potassium measurements and 57 607 individuals with an outpatient hyperkalemia value >6.2 mmol/L. Of these, 7469 (13.0%) individuals had an ED encounter within 24 hours. Individuals with an ED encounter had more comorbidities, higher medication use, and more prior healthcare utilization. Within 7 days of the hyperkalemia report, 675 of the 57 607 individuals (1.2%) had died. Where data were available, the first potassium value within 24 hours of an ED encounter was 1.5 mmol/L (± SD 1.3) lower, on average, than the initial outpatient potassium value. Limitations: All-cause mortality may not be attributable to the hyperkalemia result. Sudden cardiac death, which is more specific to hyperkalemia, is not completely captured in our data sources. Data for medications are limited to patients 65 years of age and older. Conclusions: Outpatient hyperkalemia is common. Despite guidelines recommending urgent treatment for patients with serum potassium levels >6.2 mmol/L, most are not referred to the ED.

Indexed as

chronic kidney diseasehyperkalemialaboratory reporting

Identifiers

PMID40756445
PMCPMC12317165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.